Rare diseases
Investigational molecules
Locations
Al. Tadeusza Kosciuszki 93, 90-436 Lodz, Poland
Dermoklinika-Medyczne Centrum s.c. M.Kierstan J.Narbutt A.Lesiak in Lodz, Poland specialises in clinical trials of conditions such as Dermatitis atopic, Psoriasis, Hidradenitis, Alopecia areata, and other specialisations. This site conducts important research.
The clinic is conducting studies that target immune system diseases such as cutaneous lupus and atopic dermatitis, aiming to evaluate new therapeutic options and long‑term safety for patients.
With a focus on innovative treatments, the research team at this Lodz facility seeks to improve outcomes for individuals living with immune‑mediated skin conditions.
Clinical investigations at Dermoklinika‑Medyczne Centrum explore skin and connective tissue diseases, concentrating on reducing disease activity in lupus erythematosus.
These trials aim to provide clearer therapeutic pathways for patients with persistent skin manifestations.
Research includes analysis of immune system processes that drive dermatologic inflammation, supporting the development of targeted interventions.
By uncovering underlying mechanisms, the site contributes to more precise and effective therapeutic strategies.
Clinical trials currently enrolling participants at this site.
Study of GHZ339 for treatment of moderate to severe atopic dermatitis
PolandStudy on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
PolandStudy on Risankizumab for Children Aged 6-17 With Moderate to Severe Plaque Psoriasis After Completing Previous Study
PolandStudy on Deucravacitinib for Children with Moderate to Severe Plaque Psoriasis
PolandStudy on the Effectiveness and Safety of ANB032, Hydrocortisone, and Alclometasone Dipropionate for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults
PolandStudy on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness and Safety of Clascoterone Solution for Treating Male Pattern Hair Loss
PolandStudy on the Effectiveness and Safety of SAR444656 for Adults with Moderate to Severe Hidradenitis Suppurativa
PolandStudy on SAR444656 for Adults with Moderate to Severe Atopic Dermatitis
PolandStudy on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis
PolandStudy on the Long-term Safety and Effectiveness of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
PolandGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
